Black–Scholes model

INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Verano Holdings Corp. with Losses of $100,000 to Contact the Firm

Retrieved on: 
Tuesday, August 2, 2022
Class Action Lawsuit, Professional Services, Legal, Verano, Ethics, SEC, SV, Canadian Securities Exchange, Board, Black–Scholes model, Certification, Audit committee, Company, Suite, Security (finance), Property management

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Verano Holdings Corp. (Verano or the Company) (OTCMKTS: VRNOF ) for violations of the securities laws.

Key Points: 
  • The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Verano Holdings Corp. (Verano or the Company) (OTCMKTS: VRNOF ) for violations of the securities laws.
  • The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
  • We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge.
  • The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

VERANO ALERT: Bragar Eagel & Squire, P.C. is Investigating Verano Holdings Corp. on Behalf of Verano Stockholders and Encourages Investors to Contact the Firm

Retrieved on: 
Tuesday, August 2, 2022
Legal, Professional Services, Audit committee, Jeanne Eagels, U.S. Securities and Exchange Commission, SV, Telephone, Canadian Securities Exchange, Board, Black–Scholes model, News, Company, P.C, Notice, Private investigator, Security (finance)

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Verano Holdings Corp. (Verano or the Company) (OTCMKTS: VRNOF) on behalf of Verano stockholders.

Key Points: 
  • Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Verano Holdings Corp. (Verano or the Company) (OTCMKTS: VRNOF) on behalf of Verano stockholders.
  • Our investigation concerns whether Verano has violated the federal securities laws and/or engaged in other unlawful business practices.
  • On this news, Verano's stock price fell $0.24 per share, or 3.72%, to close at $6.22 per share on July 28, 2022.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in Verano Holdings Corp. with Losses of $100,000 to Contact the Firm

Retrieved on: 
Tuesday, August 2, 2022
Class Action Lawsuit, Professional Services, Legal, Verano, Ethics, SEC, SV, Canadian Securities Exchange, Board, Black–Scholes model, Certification, Audit committee, Company, Â, Suite, Security (finance), Property management

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Verano Holdings Corp. (Verano or the Company) (OTCMKTS: VRNOF ) for violations of the securities laws.

Key Points: 
  • The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Verano Holdings Corp. (Verano or the Company) (OTCMKTS: VRNOF ) for violations of the securities laws.
  • The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
  • We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge.
  • The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Verano Holdings Corp. - VRNOF

Retrieved on: 
Monday, August 1, 2022
Company, GLOBE, U.S. Securities and Exchange Commission, Verano, SV, Canadian Securities Exchange, Board, Black–Scholes model, News, Audit committee, Pomerantz, Notice

NEW YORK, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Verano Holdings Corp. (Verano or the Company) (OTCMKTS: VRNOF).

Key Points: 
  • NEW YORK, Aug. 01, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Verano Holdings Corp. (Verano or the Company) (OTCMKTS: VRNOF).
  • Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext.
  • The investigation concerns whether Verano and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

Verano to Restate Previously Issued Financial Statements

Retrieved on: 
Wednesday, July 27, 2022
Audit committee, Quarter, GLOBE, U.S. Securities and Exchange Commission, Consolidated, SEC, SV, Canadian Securities Exchange, Black–Scholes model, SEDAR, Mission statement, Interim, Company, Security (finance), System, CSE, Form 10-K, Annual report, Cryptocurrency, Animal, Bookkeeping

CHICAGO, July 27, 2022 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) (Verano or the Company), a leading multi-state cannabis company, today announced as a result of internal compensation and tax reviews, certain accounting errors were uncovered and it will be required to restate each of the previously issued financial statements set forth below (collectively, the Prior Period Financials), all of which, together with all related disclosures, previously furnished or filed reports, earnings releases, investor presentations or similar communications, should therefore no longer be relied upon.

Key Points: 
  • CHICAGO, July 27, 2022 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) (Verano or the Company), a leading multi-state cannabis company, today announced as a result of internal compensation and tax reviews, certain accounting errors were uncovered and it will be required to restate each of the previously issued financial statements set forth below (collectively, the Prior Period Financials), all of which, together with all related disclosures, previously furnished or filed reports, earnings releases, investor presentations or similar communications, should therefore no longer be relied upon.
  • Verano is a leading, vertically integrated, multi-state cannabis operator in the U.S., devoted to the ongoing improvement of communal wellness by providing responsible access to regulated cannabis products.
  • With a mission to address vital health and wellness needs, Verano produces a comprehensive suite of premium, innovative cannabis products sold under its trusted portfolio of consumer brands, including Verano, Avexia, Encore, and MV.
  • Verano designs, builds, and operates dispensaries under retail brands including Zen Leaf and MV, delivering a superior cannabis shopping experience in both medical and adult-use markets.

SECURITY MATTERS LIMITED Announces Business Combination With LIONHEART III CORP (LION)

Retrieved on: 
Tuesday, July 26, 2022
Benchmark, Board of directors, Black–Scholes model, ESG, LLC, Australian Securities Exchange, Goal, Acquisition, Court, Cyprus Securities and Exchange Commission, ESOP, Corporations Act 2001, Piper, Advisory board, Scheme, EF Hutton, Technology, Capital, Memory, SPAC, Report, GLOBE, SID, Industry, Consideration, CEO, Board, ASX, DLA Piper, Founder, BCA, III Corps (United States), Option, History, Recycling, U.S. Securities and Exchange Commission, Part, NASDAQ, Anglo Irish Bank Corporation Act 2009, Transaction, Efficiency, Security (finance), Holding company, Iron ore, Bank, Agriculture, Management, Lionheart, SMX

SMX CEO Haggai Alon commented: SMX is thrilled to join Lionheart in our entry into the US public market.

Key Points: 
  • SMX CEO Haggai Alon commented: SMX is thrilled to join Lionheart in our entry into the US public market.
  • Ophir Sternberg, CEO and Founder of Lionheart Capital, commented: Lionheart is honored to welcome SMX to our portfolio of diverse and exciting business endeavors.
  • EF Hutton, a division of Benchmark Investments, LLC, is serving as financial advisor to Lionheart III Corp. K&L Gates, Afik & Co Attorneys & Notary and Arthur Cox LLP are serving as legal counsel to SMX.
  • DLA Piper is serving as legal counsel to Lionheart III Corp. Futerra will act as SMXs global brand strategy agency.

HIVE Achieves Record Annual Revenue Ended March 31, 2022 of $211 Million and Earnings of $79 Million with a 545% Growth in BTC Mining Hashrate

Retrieved on: 
Wednesday, July 20, 2022
Ethereum, Bitcoin, Sale, ETH, IAS, Black–Scholes model, IAS 2, Industry, Legislation, Twitter, HIVE, Phrase, Income, Risk, IAS 38, Webcast, News, Adoption, IFRS, Mining, Mission statement, COO, Company, MD, BTC, Efficiency, Follow, Intangible asset, Analysis, Inventory, ESG, Growth, Audit, Cryptocurrency

A reconciliation to its nearest IFRS measures is provided under "Reconciliations of Non-IFRS Financial Performance Measures" in the Companys MD&A.

Key Points: 
  • A reconciliation to its nearest IFRS measures is provided under "Reconciliations of Non-IFRS Financial Performance Measures" in the Companys MD&A.
  • There was no significant impact to the consolidated financial statements as a result of this change for the year ended March 31, 2021.
  • Management will host a webcast on Wednesday, July 20, 2022 at 4:00 pm Eastern Time to discuss the Companys financial results.
  • Since the beginning of 2021, HIVE has held in secure storage the majority of its ETH and BTC coin mining rewards.

Biostage Announces $5.1 Million Financing to Advance Clinical Trial

Retrieved on: 
Friday, May 13, 2022
Interim, Birth, Company, Private placement, Mayo Clinic, Private Securities Litigation Reform Act, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Lung, Food, European Medicines Agency, Patient, Goal, Trauma, NASDAQ, Esophagus, OTC, BEI, Clinical trial, Investor, Clinical professor, Private, Esophageal cancer, FDA, Esophageal disease, Black–Scholes model, Time, Safety, Technology, Regeneration, Warrant, Cancer, OTCQB, Risk, Annual report, Pharmaceutical industry, Security (finance)

The funds will be used to accelerate the clinical development of Biostage's lead product candidate, the Biostage Esophageal Implant, or BEI.

Key Points: 
  • The funds will be used to accelerate the clinical development of Biostage's lead product candidate, the Biostage Esophageal Implant, or BEI.
  • The FDA has approved a ten-patient phase one and phase two clinical trial to study the repair of damage to the esophagus in adults caused by cancer or injury.
  • Hence, the Company expects the repair of birth defects in the esophagus to be an additional indication for which Biostage will seek FDA approval.
  • Biostage is also developing other uses of its technology such as for treating cancer of the lung using the Biostage Bronchial Implant.

Kelso Technologies Inc. Financial Results for the Three Months Ended March 31, 2022

Retrieved on: 
Thursday, May 12, 2022
Risk, Engineering, Achievement, Company, EBITDA, Risk management, EDGAR, Director, News, Investment, Solution, Tax, Transport, OEM, COVID-19, Industry, Adjustment, Legislation, Ethanol, Research, Method, Black–Scholes model, Probability, Forward-looking statement, Compliance, Board, Suite, IFRS, Growth, Bookkeeping, Online gambling, Oil, Fine chemical

The working capital position of the Company as at March 31, 2022 was $8,845,629 compared to $8,670,165 as at December 31, 2021.

Key Points: 
  • The working capital position of the Company as at March 31, 2022 was $8,845,629 compared to $8,670,165 as at December 31, 2021.
  • Net assets of the Company remained steady at $12,000,977 as at March 31, 2022 compared to $12,055,113 as at December 31, 2021.
  • The Company had no interest-bearing long-term liabilities or debt as at March 31, 2022.
  • New tank car demand is expected to grow to 10,000 tank cars in 2022 and 13,450 tank cars in 2023.

Softchoice Announces First Quarter 2022 Results

Retrieved on: 
Thursday, May 12, 2022
Data Management, Security, Technology, Software, Internet, Hardware, Stock dilution, Income, Software, Company, EBITDA, EPS, Indian stock exchange, Fiscal, AIF, News, Policy, Public expenditure, Tax, Nature, RSU, Workplace, COVID-19, Adjustment, TSX, Cathy O'Brien (conspiracy theorist), Accounting, Industry, Black–Scholes model, TTM, Budget, Organization, Risk, System, IPO, Social Democrats (Slovenia), Phrase, Growth, Project, Completion, Security (finance), Insurance, Risk management, Lease

The costs in Q1 2022 relate to system enhancements after the implementation of Project Monarch.

Key Points: 
  • The costs in Q1 2022 relate to system enhancements after the implementation of Project Monarch.
  • As at March 31, 2022, $49.8 million has been invested in operating and capital expenditures for Project Monarch and related system enhancements.
  • Lease payments in the TTM Q1 2022 included a one-time early lease termination payment of $0.5 million, which occurred in Q3 2021.
  • If we do not achieve the anticipated results, we may modify or discontinue certain of our other planned business initiatives.